Van Lanschot Kempen Investment Management N.V. Sells 395,792 Shares of Envista Holdings Corporation $NVST

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

Van Lanschot Kempen Investment Management N.V. reduced its holdings in shares of Envista Holdings Corporation (NYSE:NVST - Free Report) by 12.7% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,722,331 shares of the company's stock after selling 395,792 shares during the quarter. Van Lanschot Kempen Investment Management N.V. owned about 1.61% of Envista worth $46,987,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of NVST. Brickwood Asset Management LLP purchased a new stake in shares of Envista during the 4th quarter valued at approximately $40,037,000. Dimensional Fund Advisors LP lifted its stake in Envista by 24.0% in the 1st quarter. Dimensional Fund Advisors LP now owns 8,387,297 shares of the company's stock worth $144,760,000 after purchasing an additional 1,625,206 shares in the last quarter. Pzena Investment Management LLC lifted its stake in Envista by 160.7% in the 1st quarter. Pzena Investment Management LLC now owns 2,294,257 shares of the company's stock worth $39,599,000 after purchasing an additional 1,414,080 shares in the last quarter. Deerfield Management Company L.P. Series C raised its position in shares of Envista by 4,949.9% during the 4th quarter. Deerfield Management Company L.P. Series C now owns 1,018,415 shares of the company's stock valued at $19,645,000 after buying an additional 998,248 shares in the last quarter. Finally, Ameriprise Financial Inc. raised its position in shares of Envista by 288.2% during the 4th quarter. Ameriprise Financial Inc. now owns 1,075,344 shares of the company's stock valued at $20,743,000 after buying an additional 798,366 shares in the last quarter.

Envista Stock Up 5.9%

Envista stock traded up $1.2090 during trading hours on Friday, hitting $21.6690. The stock had a trading volume of 1,558,799 shares, compared to its average volume of 2,617,570. The stock's 50-day moving average price is $20.04 and its 200-day moving average price is $18.57. Envista Holdings Corporation has a 12-month low of $14.22 and a 12-month high of $23.00. The stock has a market capitalization of $3.60 billion, a P/E ratio of 67.72, a price-to-earnings-growth ratio of 1.16 and a beta of 1.00. The company has a quick ratio of 2.08, a current ratio of 2.44 and a debt-to-equity ratio of 0.46.

Envista (NYSE:NVST - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The company reported $0.26 EPS for the quarter, topping analysts' consensus estimates of $0.24 by $0.02. Envista had a net margin of 2.11% and a return on equity of 4.84%. The firm had revenue of $682.10 million during the quarter, compared to analyst estimates of $638.21 million. During the same period in the previous year, the business posted $0.11 earnings per share. The business's revenue for the quarter was up 7.7% on a year-over-year basis. Envista has set its FY 2025 guidance at 1.050-1.15 EPS. Equities research analysts anticipate that Envista Holdings Corporation will post 1 EPS for the current fiscal year.

Analysts Set New Price Targets

Several research firms have recently weighed in on NVST. Wall Street Zen upgraded shares of Envista from a "buy" rating to a "strong-buy" rating in a research report on Saturday, August 2nd. Morgan Stanley raised their price target on shares of Envista from $16.00 to $17.00 and gave the stock an "equal weight" rating in a report on Friday, August 1st. Mizuho raised their price target on shares of Envista from $15.00 to $18.00 and gave the stock an "underperform" rating in a report on Friday, August 1st. Baird R W raised shares of Envista from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, May 27th. Finally, Robert W. Baird raised shares of Envista from a "neutral" rating to an "outperform" rating and raised their target price for the stock from $21.00 to $23.00 in a research report on Tuesday, May 27th. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, nine have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus target price of $20.92.

About Envista

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.